# Antibiotics for Kidney Transplant Recipients

> **NCT07106125** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 50 (estimated)

## Conditions studied

- Kidney Transplant
- Urinary Tract Infection(UTI)
- Antibiotic Prophylaxis
- Remote Patient Monitoring
- Feasibility Pilot Study

## Interventions

- **DRUG:** Trimethoprim-Sulfamethoxazole (TMP-SMX)
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT07106125
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11
- **Primary completion:** 2028-12
- **Final completion:** 2029-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07106125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07106125, "Antibiotics for Kidney Transplant Recipients". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07106125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*